This Mdivi-1 is a quinazolinone, just like our ATH434, however, of course, they have some differences. To understand how Mdivi-1 was found and what kind of qualifications it has, you can go to this paper, published 16 years ago:
Most likely this paper is somehow related to how 434 inventors came to the solution to select quinazoline as a potential drug for mitochondrial diseases. There are a lot of experimental papers with Mdivi-1.
So it is not a wonder that our 434 is a mitochondrion drug and because of that there will many different diseases it can help.
ATH Price at posting:
1.1¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)